The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: Parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine

Journal of Veterinary Pharmacology and Therapeutics

Volumn 21, Issue 3, 1998, Pages 214-222

  Hewson, C J ^a,d   Conlon, P D ^a   Luescher, U A ^a,b   Ball, R O ^a,c  

^a UNIVERSITY OF GUELPH   (Canada)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d 2 Wenderton Farm Cottages ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; NORCLOMIPRAMINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; COMPULSION; DEPRESSION; DOSE RESPONSE; DRUG HALF LIFE; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BINDING; SYNAPTIC TRANSMISSION;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DOG DISEASES; DOGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; MALE; MENTAL DISORDERS;

EID: 0031778378     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1998.00138.x     Document Type: Article

References (31)

1. American Psychiatric Association (1994) DSM IV. In Diagnostic and Statistical Manual of Mental Disorders, 4th edn. p. 418. American Psychiatric Association, Washington, DC.
2. Baggot, D.J. (1977) Principles of Drug Disposition in Domestic Animals. pp. 145-155. WB Saunders, Philadelphia.
3. Balant-Gorgia, A.E., Gex-Fabry, M. & Balant, L.P. (1991) Clinical pharmacokinetics of clomipramine. Clinical Pharmacokinetics, 20, 447-462.
4. Baldessarini, R.J. (1996) Drugs and the treatment of psychiatric disorders. Depression and mania. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. Eds Hardman, J.G., Goodman, A.G. & Limbird, L.E, pp. 431-445. McGraw-Hill, New York.
5. Benfield, D.P., Harries, C.M. & Luscombe, D.K. (1980) Some pharmacological aspects of desmethylclomipramine. Postgraduate Medical Journal, 56(Suppl. 1), 13-18.
6. Brosen, K. & Gram, L.F. (1989) Clinical significance of sparteine/ debrisoquine oxidation polymorphism. European Journal of Clinical Pharmacology, 36, 537-547.
7. Crewe, H.K., Lennard, M.S., Tucker, C.T., Woods, F.R. & Haddock, R.E. (1992) The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D) activity in human liver microsomes. British Journal of Clinical Pharmacology, 34, 262-265.
8. Evans, L.E.J., Bett, J.H.N., Cox, J.R., Dubois, J.P. & van Hees, T. (1980) The bioavailability of clomipramine (Anafranil). Progress in NeuroPsychopharmacology, 4, 293-302.
9. Faigle, J.W. & Dieterle, W. (1973) The metabolism and pharmacokinetics of clomipramine. Journal of International Medical Research, 1, 281-290.
10. Friedman, E. & Cooper, T.B. (1983) Pharmacokinetics of chlorimipramine and its demethylated metabolites in blood and brain regions of rats treated acutely and chronically with chlorimipramine. Journal of Pharmacology and Experimental Therapeutics, 225, 387-390.
11. Gibaldi, M. (1984) Biopharmaceutics and Clinical Pharmacokinetics 3rd edn, pp. 12-40. Lea and Febiger, Philadelphia.
12. Godbillon, J. & Gauron, S. (1981) Determination of clomipramine or imipramine and their mono-demethylated metabolites in human blood or plasma by high-performance liquid chromatography. Journal of Chromatography, 204, 303-311.
13. Goldberger, E. & Rapoport, J.L. (1991) Canine acral lick dermatitis: response to the anti-obsessional drug clomipramine. Journal of the American Animal Hospital Association. 27, 179-182.
14. Hall, H. & Ogren, S.-O. (1981) Effects of antidepressant drugs on different receptors in the brain. European Journal of Pharmacology, 70, 393-407.
15. Hewson, C.J. & Luescher, U.A. (1996) Compulsive disorder in dogs. In Readings in Companion Animal Behavior. Eds Voith, V.L. & Borchelt, P.L. pp. 153-158. Veterinary Learning Systems. Trenton, New Jersey.
16. Hewson, C.J., Luescher, U.A., Parent, J.M., Conlon, P.D., Ball, R.O. (1998) Efficacy of clomipramine in the treatment of canine compulsive disorder. Journal of the American Veterinary Medical Association (in press).
17. McTavish, D, & Benfield, P. (1990) Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs, 39, 136-153.
18. Metzler, C.M. & Weiner, D.L. (1992) PCNONLIH User Guide. 4th edn, pp. 3.3-3.7 SCI Software, Lexington, Kentucky.
19. Myers, R.H. (1990) Classical and Modern Regression with Applications. 2nd edn. p. 280. Duxbury Press, Belmont, California.
20. Nagy, A. & Johansson, R. (1977) The demethylation of imipramine and clomipramine as apparent from their pharmacokinetics. Psychophary macology, 54, 125-131.
21. Nemeroff, C.B., DeVane, C.L. & Pollock, B.G. (1996) Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311-320.
22. Overall, K.L. (1992) Recognition, diagnosis and management of obsessive-compulsive disorders: Part 1. Canine Practice, 17, 40-44.
23. Overall, K.L. (1994) Use of clomipramine to treat ritualistic stereotypic motor behavior in three dogs. Journal of the American Veterinary Medical Association, 205, 1733-1741.
24. Peck, C.C., Sheiner, L.B. & Nichols, A.I. (1984) The problem of choosing weights in nonlinear regression analysis of pharmacokinetic data. Drug Metabolism Reviews, 15, 133-148.
25. Powers, J. (1990) Statistical analysis of pharmacokinetic data. Journal of Veterinary Pharmacology and Therapeutics, 13, 113-120.
26. Preskorn, S.H. (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. Journal of Clinical Psychiatry, 54(Suppl.), 14-34.
27. Rapoport, J.L., Ryland, D.H. & Kriete, M. (1992) Drug treatment of canine acral lick. An animal model of obsessive compulsive disorder. Archives of General Psychiatry, 49, 517-521.
28. Sioufi, A., Pommier, F. & Dubois, J.F. (1988) Simultaneous determination of clomipramine and its N-demethylated metabolite in human whole blood by capillary gas chromatography. Journal of Chromatography, 428, 71-80.
29. Spilker, B. (1986) Guide to the Clinical Interpretation of Data. pp. 145-157. Raven Press, New York.
30. Welling, P.G. (1989) Effects of food on drug absorption. Pharmacology and Therapeutics, 43, 425-441.
31. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.